Background The Human Papillomavirus (HPV) vaccine has offered a great promise to
reduce the cervical cancer burden; its utilization (uptake) however has been lagging …

Background. Cervical cancer is Ethiopia's second biggest cause of cancer‐related death
among women. The introduction of human papilloma virus (HPV) vaccination is expected to …

Background The human papillomavirus vaccine is one of the main preventative measures
for cervical cancer. However, global vaccine uptake is low; the problem is particularly acute …

Background Human papillomavirus infection, a causative factor for cervical cancer, remains
a topic of great interest. About 80% of sexually active women are at risk of acquiring HPV …

Background Cervical cancer is one of the profound threats to women's lives and the fourth
most common cancer among women. Ethiopia launched the human papilloma vaccination …

Introduction: Human papillomavirus infections are the most prevalent sexually transmitted
disease among women worldwide. Cervical cancer is the second-most frequent disease …

Background Human papillomavirus vaccine uptake among school girls in Ethiopia was still
low and uptake was majorly related to perception regarding the vaccine. This study explored …

Background Cervical cancer is the fourth most common cancer affecting females. Human
papillomavirus vaccination of adolescent girls is the primary strategy for cervical cancer …

Objective This study aimed to assess the knowledge and acceptability of the human
papillomavirus (HPV) vaccine and associated factors among female adolescent students in …

Background Cervical cancer is currently the second-leading cause of cancer death among
women in Ethiopia. Vaccination against the human papillomavirus (HPV) is an effective …